303 LUPIN Pill - white oval, 19mm
Pill with imprint 303 LUPIN is White, Oval and has been identified as Cefuroxime Axetil 500 mg. It is supplied by Lupin Pharmaceuticals, Inc.
Cefuroxime is used in the treatment of Bladder Infection; Bacterial Infection; Bronchitis; Bone infection; Epiglottitis and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefuroxime 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 303 LUPIN
Cefuroxime Axetil
- Imprint
- 303 LUPIN
- Strength
- 500 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Second generation cephalosporins
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lupin Pharmaceuticals, Inc.
- Inactive Ingredients
-
microcrystalline cellulose,
croscarmellose sodium,
hypromellose 2910 (15 mPa.s),
hypromellose 2910 (5 mPa.s),
polyethylene glycol 4000,
propylene glycol,
silicon dioxide,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 68180-0303 | Lupin Pharmaceuticals, Inc. |
| 60505-2682 (Discontinued) | Apotex Corp. |
More about cefuroxime
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (150)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: second generation cephalosporins
- Breastfeeding
- En español
Patient resources
- Cefuroxime oral/injection drug information
- Cefuroxime (Injection, Intravenous) (Advanced Reading)
- Cefuroxime (Oral) (Advanced Reading)
- Cefuroxime Tablets
- Cefuroxime Injection
- Cefuroxime Oral Suspension
Other brands
Professional resources
- Cefuroxime monograph
- Cefuroxime Axetil (FDA)
- Cefuroxime Axetil Oral Suspension (FDA)
- Cefuroxime Dextrose (FDA)
- Cefuroxime Injection (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.